No Data
No Data
ADRs End Higher; TC BioPharm (Holdings) PLC Climbs 30%
Top Premarket Decliners
Affirm Shares Are Trading Higher 30%
TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering
Exicure XCUR Post-Reverse Split; TC BioPharm TCBP European Patent
TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications
No Data